Ralf Kuriyel
Chief Tech/Sci/R&D Officer chez REPLIGEN CORPORATION
Fortune : 5 M $ au 29/02/2024
Profil
Actuellement, Ralf Kuriyel est vice-président senior chargé de la recherche et du développement chez Repligen Corp. Auparavant, il a été vice-président de la recherche et du développement chez Pall Life Sciences et vice-président de la recherche et du développement des applications sur le terrain chez Pall Corp. M. Kuriyel a obtenu un diplôme de premier cycle et un diplôme d'études supérieures de l'Institut polytechnique de Rensselaer.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
REPLIGEN CORPORATION
0,04% | 11/03/2024 | 24 260 ( 0,04% ) | 5 M $ | 29/02/2024 |
Postes actifs de Ralf Kuriyel
Sociétés | Poste | Début |
---|---|---|
REPLIGEN CORPORATION | Chief Tech/Sci/R&D Officer | 18/10/2016 |
Anciens postes connus de Ralf Kuriyel
Sociétés | Poste | Fin |
---|---|---|
PALL CORPORATION | Corporate Officer/Principal | 01/10/2016 |
Cytiva US LLC
Cytiva US LLC BiotechnologyHealth Technology Part of Danaher Corp., Cytiva US LLC is a private company that specializes in aerospace filtration technology. The company is based in Marlborough, MA. The company push the limits of what's possible to enable the next generation of air travel. | Chief Tech/Sci/R&D Officer | 01/10/2016 |
Formation de Ralf Kuriyel
Tufts University | Doctorate Degree |
Rensselaer Polytechnic Institute | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
REPLIGEN CORPORATION | Health Technology |
Entreprise privées | 2 |
---|---|
Pall Corp.
Pall Corp. Medical SpecialtiesHealth Technology Pall Corp. designs, manufactures, and markets filtration and separation equipment. Its products are used to remove solid, liquid, and gaseous contaminants from a variety of liquids and gases. The firm has Life Sciences and Industrial segments. The Life Sciences segment focuses on developing, manufacturing, and selling products to customers in the medical, biopharmaceuticals, and food and beverage markets. The Industrial segment focuses on developing, manufacturing and selling products to customers in the process technologies, aerospace, and microelectronics markets. The company was founded by David B. Pall on July 31, 1946 and is headquartered in Port Washington, NY. | Health Technology |
Cytiva US LLC
Cytiva US LLC BiotechnologyHealth Technology Part of Danaher Corp., Cytiva US LLC is a private company that specializes in aerospace filtration technology. The company is based in Marlborough, MA. The company push the limits of what's possible to enable the next generation of air travel. | Health Technology |